Covaxin has been indigenously developed in collaboration with ICMR. An expert panel from India’s central drug authority recommended on January 2 to grant permission for the emergency restricted use of the locally developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar instructions for the COVID vaccine. -19 …
Read More »
Bharat Biotech has around 10 million vaccine doses ready, Dr. Savita Verma told NDTV (file) New Delhi: Covaxin, the coronavirus vaccine from Hyderabad-based Bharat Biotech, has been recommended for “restricted use in emergency situations of public interest” by a government-appointed panel, which presented its findings to the General Controller of …
Read More »
Coronavirus News LIVE Updates: India is holding nationwide drills today to kick off one of the world’s largest coronavirus vaccination programs as the drug regulator prepared to approve the first vaccine. A government panel on Friday recommended the emergency use of the AstraZeneca-Oxford University injection and the first injections could …
Read More »
NEW DELHI: The Subject Matter Expert Committee (SEC) of the national drug regulator is likely to hold a meeting with Bharat Biotech on Saturday to consider your Covid-19 vaccine applicant, Covaxin. The committee constituted by the Central Organization for the Control of Medicines Standards on Friday had held that the …
Read More »
New Delhi: A panel of government experts will meet today to review Bharat Biotech’s request for the emergency use of its Covaxin vaccine, India’s first COVID-19 jab developed indigenously in collaboration with the country’s leading medical research body. country, ICMR. The development comes a day after the Subject Matter Experts …
Read More »
NEW DELHI: The Committee of Experts on Matter of the Central Organization for the Control of Medicines Standards on Friday has maintained that the data provided by Bharat Biotech for its coronavirus vaccine ‘Covaxin’ is not sufficient for the granting of emergency use approval and has asked for more information, …
Read More »
NEW DELHI: The drug regulator’s Subject Matter Experts Committee (SEC) recommended on Friday the granting of an Emergency Use Authorization (USA) for the Serum Institute of India’s ‘Covishield’, raising hopes that it will soon be Covid vaccine available in India. The sources said that the SEC has recommended the EUA …
Read More »
NEW DELHI: India is poised to celebrate New Years Day by giving its first approval to a coronavirus vaccine. The expert panel is likely to approve the vaccine developed by AstraZeneca and the University of Oxford for emergency use on Friday, Reuters reported, citing sources. If approved, India will become …
Read More »
Among the Center’s elaborate plan to distribute the vaccine against the coronavirus disease (Covid-19), are the country’s air and road transport network and the sites where the vaccine will be administered to eligible people in the first phase. On Friday, the subject matter expert committee (SEC) of the Central Medicines …
Read More »
NEW DELHI: The drug regulator’s Subject Matter Expert Committee (SEC) on the Covid-19 vaccine sought more time to analyze updated data submitted by the Serum Institute of India and Bharat Biotech for emergency use authorization (USA ) for their respective SARS vaccine candidates. CoV2. The committee will meet again on …
Read More »